| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 26.000 | 47.169 | 54.996 | 5.203 | 3.578 | 11.167 | 24.436 | 2.503 | 0 |
| Total Income - EUR | - | 26.157 | 48.104 | 55.506 | 6.575 | 3.579 | 11.167 | 24.461 | 2.503 | 0 |
| Total Expenses - EUR | - | 110 | 641 | 822 | 547 | 204 | 185 | 145 | 464 | 109 |
| Gross Profit/Loss - EUR | - | 26.048 | 47.463 | 54.684 | 6.028 | 3.375 | 10.982 | 24.316 | 2.039 | -109 |
| Net Profit/Loss - EUR | - | 25.263 | 46.030 | 53.032 | 5.840 | 3.273 | 10.688 | 23.597 | 1.719 | -109 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Acl Med 2016 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 237 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 26.167 | 52.734 | 80.917 | 7.629 | 4.445 | 12.105 | 32.733 | 4.251 | 4.082 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 11.125 | 7.640 | 4.125 | 569 | 484 | 1.794 | 14.764 | 404 | 14 |
| Cash | - | 15.042 | 45.093 | 76.792 | 7.060 | 3.960 | 10.312 | 17.969 | 3.846 | 4.068 |
| Shareholders Funds | - | 25.308 | 46.082 | 53.084 | 5.891 | 3.322 | 11.510 | 23.646 | 1.768 | 1.649 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.096 | 6.751 | 27.834 | 1.739 | 1.123 | 595 | 9.087 | 2.483 | 2.433 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Acl Med 2016 Srl